To learn more about diabetic foot wounds visit my website
www.healmyfootwoundfast.com
Educational power point on foot wounds relating to:
1. Obesity in America
2. The Epidemic of Diabetes
3. Complications of Diabetes
4. Cost Realities of Diabetes
5. Chronic Foot Ulcers
Dr. Donald Pelto
299 Lincoln Street Suite 202
Worcester, MA 01605
The Diabetic Foot: What You Need to KnowOmar Haqqani
Authored by Dr. Jeffrey Stone, DPM. Presented at the First Annual Omar P. Haqqani MD Vascular Symposium, November 10, 2106, Midland Country Club, Midland, MI.
The Diabetic Foot: What You Need to KnowOmar Haqqani
Authored by Dr. Jeffrey Stone, DPM. Presented at the First Annual Omar P. Haqqani MD Vascular Symposium, November 10, 2106, Midland Country Club, Midland, MI.
Chronic kidney disease (CKD) is a global public health problem
worldwide. The worldwide prevalence of CKD has increased in
various countries such as the U.S. (13.1%), Taiwan (9.8-11.9%),
Norway (10.2%), Japan (12.9-15.1%) China (3.2-11.3%), Korea (7.2- 13.7%), Thailand (8.45-16.3%), Singapore (3.2-18.6%), and Australia(11.2%)
Approach to Support Diabetes through Data Visualization DivyaBastola
Used Tableau to created a Geo-map by zip codes, Bar chart by sex and race, and another Bar chart by age to display the dense of diabetes prevalence in 17 zip codes of North Texas.
Literature Review is conducted to demonstrate the reduction of hyperglycemia events after the implementation of an inpatient multidisciplinary glucose control management program.
Created Info-graphic to exhibit the ways to manage diabetes through education, counseling, meal/diet, and exercise and potential comorbidities in the diabetic patient that undergoes surgeries.
Our aim is to alleviate human suffering related to diabetes and its complications among those least able to withstand the burden of the disease. From 2002 to March 2017, the World Diabetes Foundation provided USD 130 million in funding to 511 projects in 115 countries. For every dollar spent, the Foundation raises approximately 2 dollars in cash or as in-kind donations from other sources. The total value of the WDF project portfolio reached USD 377 million, excluding WDF’s own advocacy and strategic platforms.
Here was a presentation I gave on toenail trauma with the slides involved. It was requested by a Worcester Emergency Resident. I hope you find it helpful. To watch video it is below the pictures.
Here is a presentation I use for patients with heel conditions. It covers plantar fasciitis, plantar fibroma, Achilles tendonitis, Haglund's deformity, posterior tibial tendonitis, Severe's Disease. To learn more about heel pain go to www.worcesterfootcare.com/heel
Here is a presentation that goes over how to treat flat feet in children. I included a link to the video on you tube.
http://www.youtube.com/watch?v=6vRpob1n2Tw
Healthcare Guide to Laser Treatment for Toenail FungusDonald Pelto
In this presentation you will discover:
2 - Ways to determine you have nail fungus
4 - Mistakes to avoid when treating nail fungus
4 - Step process for treating your fungal nails with laser therapy
Presentation of information for a comprehensive diabetic foot examination that is used in conjunction with the exam. Healthcare guide to diabetes and your feet can be obtained at www.drpelto.com
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
2. Obesity in America
Obesity in the U.S. has reached epidemic levels and poses a
continued threat to public health. For millions of Americans this
condition leads to dangerous comorbidities and costly
treatments. Because there is no single cause of obesity, the
condition remains difficult to both prevent and treat.
3.
4. An Epidemic
of Diabetes
There is a strong correlation between people who suffer from
obesity and people who develop type 2 diabetes. Consequently,
as the obesity epidemic has grown in recent years, the
incidence of type 2 diabetes has also increased across
populations. Those who develop this condition can be affected
by debilitating complications, and higher health care costs.
5.
6.
7. A Serious
Complication
Nearly a quarter of people with diabetes will develop a diabetic
foot ulcer (DFU). Despite the prevalence and disabling
consequences of a DFU, many lack awareness of this serious
diabetic complication. DFUs open the door for infection; the
longer the DFU persists, the greater the risk of hospitalization
and infections like MRSA. Diabetic patients with a DFU are at
significantly increased risk for amputation and loss of life.
8.
9.
10. Cost Realities
The magnitude of the challenge is reflected in the high cost of
treatment. The economic burden of DFUs and the
complications arising from them are enormous. One of the
most important cost-saving considerations in caring for the
patient with a DFU is expeditious and complete wound
healing to avoid serious complications.
11.
12. The Chronic Ulcer
Diabetic foot ulcers often fail to heal because persistently high
concentrations of pro-inflammatory cytokines in the wound induce
high concentrations of proteases, which degrade multiple growth
factors, receptors, and matrix proteins that are essential for wound
healing. Even with good, standard wound care, healing neuropathic
ulcers in patients with diabetes continues to be a challenge.
13.
14. References
1. Prevalence of Overweight, Obesity, and Extreme Obesity Among Adults: United States, Trends 1960–1962 Through 2007–2008. Centers for Disease Control website. Available at http://www.cdc.gov/NCHS/data/hestat/obesity_
adult_07_08/obesity_adult_07_08.pdf. Accessed 8 February 2012.
2. Obesity Trends Among US Adults between 1985 and 2010. BRFSS, Centers for Disease Control website. Available at http://www.cdc.gov/obesity/downloads/ obesity_trends_2010.ppt. Accessed 25 January 2012.
3. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011.
Available at http://www.cdc.gov/diabetes/pubs/pdf/ ndfs_2011.pdf. Accessed 8 February 2012.
4. F. Xavier Pi-Sunyer MD, MPH and the NHLBI Obesity Education Initiative Expert Panel on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults Clinical Guidelines on the Identification, Evaluation, and Treatment of
Overweight and Obesity in Adults – The Evidence Report. The National Institutes of Health National Heart, Lung, and Blood Institute. NIH Publication No. 98-4083 September 1998. Available at:
http://www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.htm
5. The Weight-control Information Network (WIN), National Institute of Diabetes and Digestive and Kidney Diseases. Do You Know the Health Risks of Being Overweight? US Department of Health and Human Services. 2007. Available at:
http://win.niddk.nih.gov/publications/health_risks.htm#type2
6. The International Diabetes Foundation, IDF Diabetes Atlas, 5th ed.: http://www.idf.org/diabetesatlas/5e/the-global-burden (Accessed 2-23-12)
7. Adapted from the IDF Diabetes Atlas, 5th ed. International Diabetes Federation, 2011. Available at http://www.idf.org/diabetesatlas/5e/the-global-burden. Accessed 17 January 2012.
8. Sprangers MA, de Regt EB, Andries F, et al. Which chronic conditions are associated with better or poorer quality of life? J Clin epidemiol. 2000;53:895- 907.
9. Wee H-L, Cheung Y-B, Shu-Chuen Li1, Kok-Yong Fong K-Y, Thumboo J. The impact of diabetes mellitus and other chronic medical conditions on health-related Quality of Life: Is the whole greater than the sum of its parts? Health and Quality of Life
Outcomes 2005, 3:2
10. Leichter S, Faulkner S, Camp J. On the Cost of Being a Diabetic Patient: Variables for Physician Prescribing Behavior. Clinical Diabetes. 2000;18(1):42-3.
11. Chester B. Good, MD, MPH. Polypharmacy in Elderly Patients With Diabetes. Diabetes Spectrum. 2002;15(4):240-248.
12. Diabetes Successes and Opportunities for Population-Based Prevention and Control, Centers for Disease Control website. Available at http://www.cdc.gov/ chronicdisease/resources/publications/AAG/ddt.htm. Accessed 8 February 2012.
13. Economic and Health Costs of Diabetes. U.S. Department of Health & Human Services website. Available at http://archive.ahrq.gov/data/hcup/highlight1/ high1.htm. Accessed 8 February 2012.
14. Lavery LA, Armstrong DG, Wunderlich RP, et al. Risk factors for foot infections in individuals with diabetes. Diabetes Care. 2006;29:1288-93.
15. Zhang Y, Hogan P. Cost effectiveness of a human fibroblast-derived dermal substitute for the treatment of diabetic foot ulcers in Medicare and commercially insured populations. Diabetes. 2011;60(suppl 1A):LB15-LB16.
16. Harrington C, Zagari MJ, Corea J, Klitenic J. Cost Analysis of Diabetic Lower Extremity Ulcers. Diabetes Care. 2000;23(9):1333-1338
17. Ndip A, Rutter MK, Vileikyte L, et al. Dialysis treatment is an independent risk factor for foot ulceration in patients with diabetes and stage 4 or 5 chronic kidney disease. Diabetes Care. 2010;33:1811-6.
18. Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999;22:382-7.
19. Singh N, Armstrong DG, Lipsky BA. Preventing Foot Ulcers in Patients With Diabetes. JAMA.2005;293(2):217-228
20. Reiber GE. Epidemiology of foot ulcers and amputations in the diabetic foot. In: Bowker JH, Pfeifer MA, eds. The Diabetic Foot. St Louis, Mo: Mosby; 2001:13-32.
21. Don Pelto, DPM, Central Massachusetts Podiatry, PC, Worcester, MA. Diabetic Foot Complications: Current Treatments and Advanced Therapies in Treating the Diabetic Foot. http://www.slideshare.net/donpelto/diabetic-foot-lecture-2010-3294772
22. Yates C, May K, Hale T, et al. Wound chronicity, inpatient care, and chronic kidney disease predispose to MRSA infection in diabetic foot ulcers. Diabetes Care. 2009;32:1907-9.
23. American Diabetes Association. Consensus development conference on diabetic foot wound care, 7-8 April 1999; Boston, MA. Diabetes Care. 1999;22:1354-60.
24. Iversen MM, Tell GS, Riise T, et al. History of foot ulcer increases mortality among individuals with diabetes: ten-year follow-up of the Nord-Trøndelag Health Study, Norway. Diabetes Care. 2010;33:2365-9.
25. Armstrong DG, Wrobel J, Robbins JM. Guest editorial: are diabetes-related wounds and amputations worse than cancer? Int Wound J. 2007;4(4):286-287.
26. Stockl K, Vanderplas A, Tafesse E, et al. Costs of lower extremity ulcers among patients with diabetes. Diabetes Care. 2004; 27: 2129-34.
27. Kruse I & Edelman S. Evaluation and treatment of diabetic foot ulcers. Clinical Diabetes. 2006;24(2):91-93.
28. Margolis DJ, Kantor J, Berlin JA. Healing of diabetic neuropathic foot ulcers receiving standard treatment. A meta-analysis. Diabetes Care. 1999; 22(5):692-695.
29. Zimny S, Voigt A, Schatz H, Pfohl M. Prediction of Wound Radius Reductions and Healing Times in Neuropathic Diabetic Foot Ulcers. Diabetes Care. 2003;26(3): 959-960.
30. Sheehan P, Jones P, Caselli A, Giurini JM, Veves A. Percent Change in Wound Area of Diabetic Foot Ulcers Over a 4-Week Period Is a Robust Predictor of Complete Healing in a 12-Week Prospective Trial. Diabetes Care. 2003; 26:1879 –1882.
31. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet. 2005;366(9498):1736-1743.
32. Barrientos S, Stojadinovic 0, Golinko MS, et al. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008;16(5):585-601.
33. Hunt TK, Hopf H, Hussain Z. Physiology of wound healing. Adv Skin Wound Care. 2000;13(Suppl 2):6-11
34. Menke NB, Diegelmann RF, Ward KR. Non-healing wounds. Emer Med Rep. 2007;28(4):38-48.
35. Snyder RJ, Kirsner RS, Warriner RA, et al. Consensus recommendations on advancing the standard of care for treating neuropathic foot ulcers in patients with diabetes. Ostomy Wound Manage. 2010;56(4 suppl):S1-S24.